脑血管病是中国居民死亡率最高的疾病，同时也是引起成人致残的最主要原因之一，其中高危非致残性脑血管病以其临床最常见、病情早期不稳定、复发风险高、及时治疗获益大等特点，近年来逐渐受到广泛关注。本项目组10余年来一直致力于寻找脑血管病的最佳干预人群、创新优化抗栓治疗方案、探寻个体化治疗新方法等，本文结合项目组取得的一系列研究结果，从高危非致残性脑血管病的早期高效识别、有效强化治疗新方案、个体化精准治疗新策略3方面内容对该类型脑血管病进行综述。
The cerebrovascular disease is the most common cause for death or adult disability among Chinese population. The High-Risk Non-Disabling Ischemic Cerebrovascular Events (HR-NICE) are very common, and they are unstable in early phases, with good prognosis after effective treatment. In recent years, the HR-NICE has gradually attracted worldwide attentions. Our work has focused on the patients with the highest stroke risk, the most effective antithrombotic therapy, and the most appropriate individualized treatment for more than 10 years. In this paper, we review the early recognition, the diagnosis and the treatment of the HR-NICE.
[1] Johnston S C, Mendis S, Mathers C D. Global variation in stroke bur-den and mortality:Eestimates from monitoring, surveillance, and model-ling[J]. Lancet Neurology, 2009, 8(4):345-354.
[2] Wang Y, Zhao X, Jiang Y, et al. Prevalence, knowledge, and treatment of transient ischemic attacks in china[J]. Neurology, 2015, 84(23):2354-2361.
[3] Li J, Wang Y, Lin J, et al. Soluble CD40L is a useful marker to predict future strokes in patients with minor stroke and transient ischemic at-tack[J]. Stroke, 2015:strokeaha.115.008685.
[4] Lin J, Zheng H, Cucchiara B L, et al. Association of lp-pla2-a and early recurrence of vascular events after tia and minor stroke[J]. Neurol-ogy, 2015, 85(18):1585-1591.
[5] Wang Y, Zhao X, Liu L, et al. Prevalence and outcomes of symptomatic intracranial large artery stenoses and occlusions in China:The chinese intracranial atherosclerosis (cicas) study[J]. Strok, 2014, 45(3):663-669.
[6] Amarenco P, Lavallée P C, Labreuche J. One-year risk of stroke after transient ischemic attack or minor stroke[J]. New England Journal of Medicine, 2016, 374(16):1533-1542.
[7] Wang Y, Wang Y, Zhao X, et al. Clopidogrel with aspirin in acute mi-nor stroke or transient ischemic attack[J]. The New England Journal of Medicine, 2013, 369:11-19.
[8] Wang Y, Pan Y, Zhao X, et al. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack (CHANCE) trial:One-year outcomes[J]. Circulation, 2015, 132:40-46.
[9] Wang X, Zhao X, Johnston S C, et al. Effect of clopidogrel with aspirin on functional outcome in tia or minor stroke:Chance substudy[J]. Neu-rology, 2015, 85(7):573-579
[10] Wang Y, Zhao X, Lin J, et al. Association between CYP2C19 loss-offunction allele status and efficacy of clopidogrel for risk reduction among patients with minor stroke or transient ischemic attack[J]. JA-MA, 2016, 316(1):70-78.
[11] Li J, Wang Y, Wang D, et al. Glycated albumin predicts the effect of dual and single antiplatelet therapy on recurrent stroke[J]. Neurology, 2015, 84(13):1330-1336.
[12] Zhou Y, Pan Y, Wu Y, et al. Effect of estimated glomerular filtration rate decline on the efficacy and safety of clopidogrel with aspirin in minor stroke or transient ischemic attack[J]. Stroke, 2016, 47(11):2791-2796.
